If you made any changes in Pure these will be visible here soon.

Research Output 2017 2017

2017

Editorial: variability in adalimumab trough and peak serum concentrations – authors’ reply

Ward, M. G., Gibson, P. R. & Sparrow, M. P., 1 Jun 2017, In : Alimentary Pharmacology and Therapeutics. 45, 11, p. 1476-1477 2 p.

Research output: Contribution to journalEditorialOtherpeer-review

29 Citations (Scopus)

Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors

Ward, M. G., Warner, R. B., Unsworth, N., Chuah, S. W., Brownclarke, C., Shieh, S., Parkes, M., Sanderson, J. D., Arkir, Z., Reynolds, J., Gibson, P. R. & Irving, P. M., 1 Jul 2017, In : Alimentary Pharmacology and Therapeutics. 46, 2, p. 150-161 12 p.

Research output: Contribution to journalArticleResearchpeer-review

16 Citations (Scopus)

Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease

Ward, M. G., Thwaites, P. A., Beswick, L., Hogg, A. J., Rosella, G., Van Langenberg, D., Reynolds, J., Gibson, P. R. & Sparrow, M. P., 1 Apr 2017, In : Alimentary Pharmacology and Therapeutics. 45, 8, p. 1135-1145 11 p.

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Is there a role for thioguanine therapy in IBD in 2017 and beyond?

Taylor, K. M., Ward, M. G., Blaker, P. A. & Sparrow, M. P., 4 May 2017, In : Expert Review of Gastroenterology & Hepatology. 11, 5, p. 473-486 14 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

60 Citations (Scopus)

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases

IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group, 1 Dec 2017, In : Alimentary Pharmacology and Therapeutics. 46, 11-12, p. 1037-1053 17 p.

Research output: Contribution to journalReview ArticleOtherpeer-review